Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDK.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.58NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-3888.18US
BA.4.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KC.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KL.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HC.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.507NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FD.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FW.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBLNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.466.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.10.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.323NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.74NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.564NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.461NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.486NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.603NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.70NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.606NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.601NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.86NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.543NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.139NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.221NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.362NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.265NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.585NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.351NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used